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Abstract
Background: Stress urinary incontinence (SUI) is a common problem. In the Netherlands, yearly 
64.000 new patients, o f whom 96% are women, consult the ir general practitioner because o f 
urinary incontinence. Approximately 7500 urodynamic evaluations and approximately 5000 
operations fo r SUI are performed every year. In all major national and international guidelines from 
both gynaecological and urological scientific societies, it  is advised to  perform urodynamics p rio r 
to  invasive treatm ent fo r SUI, but neither its effectiveness nor its cost-effectiveness has been 
assessed in a randomized setting.
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The Value o f Urodynamics p rio r to  Stress Incontinence Surgery (VUSIS) study evaluates the 
positive and negative effects w ith regard to  outcome, as well as the costs o f urodynamics, in women 
w ith symptoms o f SUI in whom surgical treatm ent is considered.
Methods/design: A  multicentre diagnostic cohort study will be performed w ith an embedded 
randomized controlled tria l among women presenting w ith symptoms o f (predominant) SUI.
Urinary incontinence has to  be demonstrated on clinical examination and/or voiding diary. 
Physiotherapy must have failed and surgical treatm ent needs to  be under consideration.
Patients w ill be excluded in case o f previous incontinence surgery, in case o f pelvic organ prolapse 
more than 1 centimeter beyond the hymen and/or in case o f residual bladder volume o f more than 
150 m illilite r on ultrasound o r  catheterisation.
Patients w ith discordant findings between the diagnosis based on urodynamic investigation and the 
diagnosis based on the ir history, clinical examination and/or m icturition diary w ill be randomized 
to  operative therapy o r  individually tailored therapy based on all available information.
Patients w ill be followed fo r tw o  years after treatm ent by the ir attending urologist o r  gynaecologist, 
in combination w ith the completion o f questionnaires.
Six hundred female patients w ill be recruited fo r registration from approximately twenty-seven 
hospitals in the Netherlands. W e  aspect that one hundred and tw o  women w ith discordant findings 
will be randomized.
The primary outcome o f this study is clinical improvement o f incontinence as measured w ith the 
validated Dutch version o f the Urinary Distress Inventory (UDI). Secondary outcomes o f this study 
include costs, cure o f incontinence as measured by voiding diary parameters, complications related 
to  the intervention, re-interventions, and generic quality o f life changes.
T ria l registration: Clinical Trials NCT00814749.
Background
Stress urinary incontinence (SUI) is a frequently occurring 
problem. The Health Council of the Netherlands esti­
mated that yearly 64.000 new patients, of whom 96% are 
women, consult their general practitioner because of uri­
nary incontinence [1].
In all major national and international guidelines of pro­
fessional organizations and authorities, it is advised to 
perform urodynamics prior to invasive treatment for SUI, 
e.g. the guidelines of the Dutch Urological Association, 
the Dutch Society of Obstetrics and Gynaecology, Interna­
tional Continence Society and European Association of 
Urology[2,3].
Usual care in the Netherlands for urinary incontinence in 
the general practitioners setting is an investigation by his­
tory, clinical examination and voiding diary. When there 
is no clear indication for urge incontinence or neurologi­
cal disease, the patient will be referred for physiotherapy. 
In case there is no improvement the patient will subse­
quently be referred to the gynaecologist or urologist [4]. 
Patient history and clinical examination are important 
aspects of the assessment of patients that suffer from stress 
urinary incontinence. Patient history is quantified by 
using parameters based on validated questionnaires and a
voiding diary for 1 to 2 days. The most common surgical 
therapy for SUI is the midurethral sling procedure of 
which the tension free vaginal tape (TVT) was first intro­
duced. These slings have an average success rate of 90% 
[5].
Urodynamics do not generate major morbidity bu t are 
generally considered as unpleasant by the patients, and 
inhere a risk of urinary tract infections as high as 20% [6]. 
Urodynamics try to enhance the understanding of lower 
urinary tract functioning and reveal the underlying 
pathology that cause patients complaints. It is an exten­
sion of patient history and physical examination in an 
unphysiological setting.
The assumption is that the urodynamic setting is capable 
of making a distinction between several pathophysiologi­
cal mechanisms causing the same micturition symptoms. 
If this holds true, the outcome of the available treatment 
options derived from the urodynamic based diagnosis 
would be better than treatment based on diagnosis made 
without urodynamics. However, the urodynamic investi­
gations that differentiate between several types of SUI and 
specify for the type of operation, lack validation and pre­
dictive value in individual cases [7].
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Moreover, since the introduction of easy to administer 
midurethral polypropylene slings, a simplified reasoning 
has found ground that states that every type of SUI is 
treated in the same way and therefore no urodynamic 
investigation would be needed.
The value of urodynamics has never been the specific sub­
ject of a randomized controlled trial [8]. Several studies 
have evaluated the value of urodynamics indirectly.
A retrospective cohort study on TVT has concluded that 
urodynamics do not have a predictive value on outcome 
after midurethral sling surgery [9]. In a randomized con­
trolled trial on Burch compared with pubovagjnal sling 
procedure, the predictive value of urodynamics was eval­
uated. Findings on urodynamic investigation did not 
seem to predict stress continence outcome [10].
The subjective and objective outcome of surgical interven­
tion with or without preoperative urodynamic investiga­
tion has not been compared, with the exception of one 
retrospective study on colposuspension and one cohort 
study on TVT [11,12]. In these two studies no differences 
were found between the groups with and without urody- 
namics.
The strong conclusion from the Cochrane Review on the 
value of urodynamics was that a randomized trial is 
needed [13].
Thus, the role of urodynamics in the objectivation of SUI 
in women is nowadays questionable and very much 
under debate. In 25-30%  of the women the symptom of 
SUI is not demonstrable probably due to the artificial sit­
uation during the investigation [5].
If urodynamics are not needed to diagnose types of SUI, 
this could be to prevent complications of surgery such as 
an overactive bladder. However in almost half of the 
patients with overactive bladder symptoms, there are no 
abnormal detrusor contractions visible on urodynamics 
[14]. On the other hand detrusor contractions during uro- 
dynamics that are regarded as the proof for overactive 
bladder complaints, can be seen in 20% of women with­
out symptoms of an overactive bladder [15]. It is therefore 
questionable, whether it can predict the therapeutic effect 
as well as the risk of complications, like de novo urgency 
or aggravation of urgency and urinary retention [7,8].
The introduction of minimally invasive techniques for 
SUI therapy, such as the midurethral tension free tape pro­
cedure, has led to an enormous increase in the num ber of 
operations in the Netherlands. In 1999, 1,600 operations 
were performed. This number has increased to over 4,000 
in 2003 and is expected to be 5,000 by today [16].
Economic relevance
We estimate that two thirds of all women with symptoms 
of SUI who had urodynamics will proceed to surgery and 
one third will be given another non-surgical intervention 
which is usually medication. From this calculation it 
appears that for this indication urodynamics are per­
formed approximately 7500 times per year in the Nether­
lands.
At expected costs of about 300 euro per test, urodynamics 
stand for 2.25 million euro health insurance charges.
In case urodynamics would be omitted, costs of possible 
extra complications are foreseen. We estimate a maximum 
of 10% additional urgency complaints [17,18]. Antimus- 
carinic treatment is available but has a record of only short 
time usage in almost all patients, and thus the costs are 
limited [19]. The other possible complication is urinary 
retention or voiding dysfunction. This occurs in less than 
5% of patients after colposuspension, bu t is less in ten­
sion free midurethral slings and is supposed not to change 
with or without urodynamics [20]. This therefore will not 
have major financial impact on the outcome. Possible fur­
ther additional costs are costs related to reoperation 
(repositioning of the sling estimated at 0.5-1% ), and out­
patients' costs.
In conclusion, it is likely that urodynamics do not have a 
role in the quality of care for women with SUI and that 
urodynamic testing in women with SUI is not cost-effec­
tive.
For this study our hypothesis was that there is no differ­
ence between outcome of surgery and individually tai­
lored therapy in women with a discrepancy between 
urodynamic findings and findings from other investiga­
tions, such as history and clinical examination. In case of 
confirmation of this hypothesis, urodynamic investiga­
tion in women with predominant SUI could be safely 
omitted.
Methods/design
The primary aim of the VUSIS study is to evaluate whether 
urodynamic testing is effective in patients with symptoms 
of SUI in whom surgical treatment is considered
The VUSIS is a multidisciplinary, multicentre diagnostic 
cohort study with a randomized controlled trial (RCT) 
embedded. All women with symptoms of predominantly 
SUI in whom surgical treatment is considered will 
undergo urodynamic investigation. Only women with a 
discordant finding compared to history and physical 
examination will be randomized. Patients with concord­
ant urodynamics will be registered [see figure 1].
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F ig u re !
S um m ary o f tr ia l design.
Study inclusion and exclusion criteria  
Inclusion
•Sym ptom s of stress urinary incontinence and/or mixed urinary 
incontinence, predominantly stress incontinence  
•Signs of s tress urinary incontinence on physical examination or 
voiding diary
•Patient is a candidate for surgical treatment (a s  based on history and 
physical examination)
•Patient has attended at least 3 months of pelvic floor exercises  
•Patient is capable to fill out bladder diaries and questionnaires and 
understands the Dutch written and spoken language
Exclusion
•Previous incontinence surgery
•Mixed urinary incontinence, urge component is predominant
•Pelvic organ prolapse > 1cm beyond the hymen on Valsalva in supine
position
•Post void urinary residual > 150ml on ultrasound or catheterisation  
•Additional pelvic surgery (prolapse and/or hysterectomy)
•Patient is or wants to becom e pregnant 
•Prior pelvic radiotherapy
F ig u re2
Study inclusion and exclusion criteria.
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The study has been approved by the institutional review 
board of the Radboud University Nijmegen Medical Cen­
tre, in Nijmegen. Ethical approval for this study has been 
obtained on 02-10-2008, num ber 2006/197.
Eligible patients will be identified by gynaecologists and 
urologists from participating hospitals in the Netherlands 
[see Additional file 1]. All women presenting with SUI 
where conservative therapy (i.e. physiotherapy) has failed 
and surgical therapy is considered, will be asked for per­
mission of registration in the study. SUI must have been 
demonstrated on physical examination and/or micturi­
tion diary. Patients will be excluded in case of previous 
incontinence surgery, in case of pelvic organ prolapse 1 
centimeter beyond the level of the hymen and/or in case 
of residual bladder volume of more than 150 ml on ultra­
sound or catheterization [see figure 2].
In all patients the following items will be recorded at 
inclusion:
1. History and clinical examination
2. 48 h-Bladder (voiding and incontinence) diary
3. Validated Quality of Life questionnaires (Short Form 
36, Euroqol 5D, Urinary Distress Inventory, Incontinence 
Impact Questionnair, Defecatory Distress Inventory)
4. Urinalysis for the detection of urinary tract infection
5. Residual urine measured by ultrasound
All women will undergo urodynamic investigation. Uro- 
dynamics will be performed according to International 
Continence Society standards and consists of free flow 
and measurement of residual, provocative filling cystom­
etry with abdominal leak point pressure measurement, 
pressure flow study and a urethral pressure profilometry 
in rest and during stress[21]. The outcomes will be 
matched with urodynamic findings to assess the poten­
tially useful parts of the urodynamic findings. Postopera­
tive urodynamics is no t part of the study.
When the result of the urodynamics does not confirm the 
history of SUI, or shows relative contra-indications for 
operation, the investigation is called discordant. Whether 
a test result is discordant is decided by the attending urol­
ogist or gynaecologist. Figure 3 demonstrates the various 
reasons for discordancy.
Women with discordant findings on urodynamics will be 
approached to participate in the randomized controlled 
part of the study.
Discordant findings on urodynamic 
investigation
•S tr e ss  incontinence is not dem onstrable
• Detrusor overactivity
• Hypocontractility of the  bladder
• Poor flow
• Residual urine 
•Outflow obstruction  
•Small cystom etric  capacity  
•Raised sensibility of the  bladder 
•Lowered sensibility of the  bladder 
•Low leve l  of com pliance
F ig u re3
D iscordant findings on urodynam ic investigation.
After they have given informed consent, the patients with 
discordant test results at urodynamics are randomly 
assigned to the study or control group. In the study group, 
the decision for intervention will be based on history and 
clinical examination only, which will be surgical treat­
ment; a midurethral sling. The choice for the kind of pro­
cedure is left to the discretion of the attending doctor. In 
the control group the decision for therapy will be based 
on history and clinical examination in combination with 
the result of the discordant findings on urodynamics. This 
includes medical treatment, prolonged physiotherapy, 
pessary treatment, bu t also surgical treatment can be one 
of the chosen therapies.
All women with SUI, who present at one of the participat­
ing hospitals, will be referred to a gynaecologist, urologist 
or a specifically appointed research nurse for counselling. 
Eligible women will receive an information sheet. Once 
women with discordant test results have given consent for 
the trial, they are randomized through a website, accord­
ing to a computer-generated randomization sequence. 
Stratification will be applied for centre. Randomization 
will be 1:1 for operative treatment and individual treat­
ment.
Patients in the RCT will be followed up from trial entry 
until the end of the study (anticipated average: two years). 
Follow-up is composed of the same items as recorded at 
inclusion.
After six weeks, six, twelve and twenty-four m onths 
patients will visit their attending gynaecologist or urolo­
gist. Physical examination will be performed and consists 
of detection of erosions, stress test for urinary leakage, and
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measurement of the residual volume. The patients will 
complete the questionnaires at all moments of follow-up.
After the intervention additional therapy is possible in 
both arms and will be recorded in the Case Record Form.
The cohort group will receive the same questionnaires 
once, at one year after the intervention.
Patient outcome measures
The primary outcome of this study is clinical improve­
ment of incontinence as measured with the validated 
Dutch version of the UDI.
Secondary outcomes of this study include costs, cure of 
incontinence as measured with voiding diaries, complica­
tions such as re-operation or overactive bladder symp­
toms, and quality of life.
The trial results will be incorporated in a diagnostic model 
to compare the current strategy (urodynamic evaluation 
in all patients) with the alternative strategy (immediate 
TVT surgery without urodynamic evaluation).
The study design will enable us to compare the costs and 
effects of the following strategies:
I. Immediate midurethral sling without preceding uro- 
dynamic evaluation.
II. Urodynamic evaluation in all patients and midure- 
thral sling depending on urodynamic evaluation 
results.
III. Sequential or probabilistic combinations, based 
on the prior probability of the fact that the urody- 
namic evaluation will change management.
Sample size considerations
The primary outcome of this study is the improvement of 
UDI at 12 months after baseline. The power calculation is 
performed using the non-inferiority assumption. The cal­
culation is based on registration of 600 patients in the 
cohort study, of whom 200 will have discordant findings. 
When approximately 50% of the women give informed 
consent for randomization, 102 women with discordant 
findings will be randomized (51 to each group). As based 
on the non-inferiority assumption, the mean improve­
m ent in UDI in both groups is expected to be 35 with 
standard deviation of 10. A difference in mean improve­
ment of 5 or less is considered as non-inferior (power 
80% using one-sided testing at 0.05).
Economic evaluation
For each patient, utilization of health care services will be 
recorded prospectively, using Case Record Forms, includ­
ing urodynamic testing, surgery for SUI, re-operations, 
medical treatment for detrusor instability, care for urinary 
incontinence, and care for urinary retention. By multiply­
ing these volumes of care with unit cost prices, direct m ed­
ical costs incurred by SUI during the follow up period will 
be calculated for each patient. For unit cost prices, 
national guidelines will be used (CVZ, 2004). For costs of 
care for urinary incontinence and urinary retention, data 
from the literature will be used, converted to 2006 prices. 
We incorporated the health related quality of life ques­
tionnaire euroqol 5D in our study to be able to calculate 
QALYs (quality-adjusted life-years), which is a measure of 
health outcome. A QALY is the change in quality of life 
induced by the treatment multiplied by the duration of 
the treatment effect and it provides the number of QALYs 
gained. QALYs can then be related to medical costs to 
arrive at a final common denominator of cost/QALY. This 
parameter can be used to compare the cost-effectiveness 
of the treatment.
Statistical analysis
Multivariate analysis of covariance with group, centre and 
the baseline covariate as independent variables will be 
used to estimate differences in improvement of the UDI 
after 12 months between the groups with 95% confidence 
intervals. As the UDI data are likely to be skewed, data will 
be log transformed prior to analysis. Other variables (i.e. 
IIQ) will be analyzed similarly.
Time plan for the VUSIS study
Patient recruitment began in January 2009 and is planned 
to continue until January 2010. The follow-up has a dura­
tion of 24 months, so will continue until January 2012. 
The study is conducted in cooperation with several centers 
ensembled in the urogynaecology consortium. Most of 
the clinics have disposition over a research nurse, who 
attributes in administration and completion of the case 
record forms. All data are collected web based.
Knowledge transfer
The outcome of the study will be important for the debate 
on the value of urodynamics. In the current international 
operative practice for SUI there is a huge increase in the 
num ber of operations. Hence the value of time consum­
ing and costly urodynamic investigations should be very 
clear. The study is planned to be a starting point for a doc­
tor's thesis. The results of our study will be submitted to 
different national and international scientific societies 
such as the International Continence Society and the 
International Urogynecologic Association, and is planned 
to be published in international scientific journals.
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